Markers of prostate region-specific epithelial identity define anatomical locations in the mouse prostate that are molecularly similar to human prostate cancers.

Although the basic functions of the prostate gland are conserved among mammals, its morphology varies greatly among species. Comparative studies between mouse and human are important because mice are widely used to study prostate cancer, a disease that occurs in a region-restricted manner within the human prostate. An informatics-based approach was used to identify prostate-specific human genes as candidate markers of region-specific identity that might distinguish prostatic ducts prone to prostate cancer from ducts that rarely give rise to cancer. Subsequent analysis of normal and cancerous human prostates demonstrated that the genes microseminoprotein-beta (MSMB) and transglutaminase 4 (TGM4) were expressed in distinct groups of ducts in the normal human prostate, and only MSMB was detected in areas of prostate cancer. The mouse orthologs of MSMB and TGM4 were then used for expression studies in mice along with the mouse ventrally expressed gene spermine binding protein (SBP). All three genes were informative markers of region-specific epithelial identity with distinct expression patterns that collectively accounted for all ducts in the mouse prostate. Together with the human data, this suggested that MSMB expression defines an anatomical domain in the mouse prostate that is molecularly most similar to human prostate cancers. Computer-assisted serial section reconstruction was used to visualize the complete expression domains for MSMB, SBP, and TGM4 in the mouse prostate. This showed that MSMB is expressed in prostatic ducts that comprise 21% of the mouse dorso-lateral prostate. Finally, the expression of MSMB, SBP, and TGM4 was evaluated in a mouse prostate cancer model created by the prostate epithelium-specific deletion of the tumor suppressor PTEN. MSMB and TGM4 were rapidly and dramatically down-regulated in response to PTEN deletion suggesting that this model of prostate cancer includes a more rapid de-differentiation of the prostatic epithelium than is observed in organ-confined human prostate cancers.

[1]  C. Lazure,et al.  A novel gene family encoding proteins with highly differing structure because of a rapidly evolving exon , 1995, FEBS letters.

[2]  S. J. Higgins,et al.  Characterization of antibodies to androgen-dependent secretory proteins of the mouse dorsolateral prostate. , 1990, Endocrinology.

[3]  M. Moussa,et al.  Knockin of SV40 Tag oncogene in a mouse adenocarcinoma of the prostate model demonstrates advantageous features over the transgenic model , 2005, Oncogene.

[4]  T. H. van der Kwast,et al.  Human prostate-specific transglutaminase: a new prostatic marker with a unique distribution pattern. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[5]  N. Greenberg,et al.  Autochthonous mouse models for prostate cancer: past, present and future. , 2001, Seminars in cancer biology.

[6]  J. Chin,et al.  Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model , 2002, Gene Therapy.

[7]  D. Price.  The accessory reproductive glands of mammals , 1961 .

[8]  Tsuey-Ming Chen,et al.  Pathobiology of autochthonous prostate cancer in a pre‐clinical transgenic mouse model , 2003, The Prostate.

[9]  J. Kawamura,et al.  Morphological and functional heterogeneity in the rat prostatic gland. , 1991, Biology of reproduction.

[10]  G. Cunha,et al.  Morphogenesis of ductal networks in the mouse prostate. , 1986, Biology of reproduction.

[11]  Guojun Wu,et al.  A novel knock-in prostate cancer model demonstrates biology similar to that of human prostate cancer and suitable for preclinical studies. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  W. C. Young.  Sex and Internal Secretions , 1962 .

[13]  T. Mizuno,et al.  Transcription of prostatic steroid binding protein (PSBP) gene is induced by epithelial-mesenchymal interaction. , 1990, Development.

[14]  D PRICE,et al.  COMPARATIVE ASPECTS OF DEVELOPMENT AND STRUCTURE IN THE PROSTATE. , 1963, National Cancer Institute monograph.

[15]  J. McNeal.  The zonal anatomy of the prostate , 1981, The Prostate.

[16]  O. S. Lowsley.  The development of the human prostate gland with reference to the development of other structures at the neck of the urinary bladder , 1912 .

[17]  G. Cunha,et al.  Permissive and instructive induction of adult rodent prostatic epithelium by heterotypic urogenital sinus mesenchyme. , 1993, Epithelial cell biology.

[18]  Hong Wu,et al.  Expression Signature of the Mouse Prostate* , 2005, Journal of Biological Chemistry.

[19]  Å. Lundwall,et al.  Organization and evolution of the glandular kallikrein locus in Mus musculus. , 2002, Biochemical and biophysical research communications.

[20]  J. Chin,et al.  In situ hybridization study of PSP94 (prostatic secretory protein of 94 amino acids) expression in human prostates , 1999, The Prostate.

[21]  Pier Paolo Pandolfi,et al.  The Multiple Roles of PTEN in Tumor Suppression , 2000, Cell.

[22]  F. S. French,et al.  Molecular cloning of rat prostate transglutaminase complementary DNA. The major androgen-regulated protein DP1 of rat dorsal prostate and coagulating gland. , 1992, The Journal of biological chemistry.

[23]  D. Kingsley,et al.  Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family. , 1996, Development.

[24]  P. Pandolfi,et al.  Pten Dose Dictates Cancer Progression in the Prostate , 2003, PLoS biology.

[25]  P. Humphrey,et al.  A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Gregory D. Schuler,et al.  Database resources of the National Center for Biotechnology Information: update , 2004, Nucleic acids research.

[27]  S. Kasper.  Survey of genetically engineered mouse models for prostate cancer: Analyzing the molecular basis of prostate cancer development, progression, and metastasis , 2005, Journal of cellular biochemistry.

[28]  P. Nelson,et al.  Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. , 2003, Cancer cell.

[29]  B. Zirkin,et al.  Regional cellular heterogeneity and DNA synthetic activity in rat ventral prostate during postnatal development. , 1991, Biology of reproduction.

[30]  B. Timms,et al.  Ductal budding and branching patterns in the developing prostate. , 1994, The Journal of urology.

[31]  P. Chaurand,et al.  A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. , 2001, Cancer research.

[32]  Ahmedin Jemal,et al.  Cancer Statistics, 2002 , 2002, CA: a cancer journal for clinicians.

[33]  P. Fernlund,et al.  Cloning of beta-microseminoprotein of the rat: a rapidly evolving mucosal surface protein. , 1996, Archives of biochemistry and biophysics.

[34]  M. Parker,et al.  Androgen regulated expression of a spermine binding protein gene in mouse ventral prostate. , 1987, Nucleic acids research.